News Conference News TCT 2021 LAA Closure Feasible in Patients With Thrombus: Registry Michael O'Riordan October 13, 2021
News Conference News TCT 2021 Failed MitraClip Is Uncommon, but Bleak When It Happens Michael O'Riordan October 08, 2021
News Daily News Diabetes Progression in Statin-Treated Patients: VA Data Michael O'Riordan October 06, 2021
News Daily News Post-ACS Patients With Low LDL Levels Remain at Risk: IMPROVE-IT Michael O'Riordan October 04, 2021
News Daily News Infective Endocarditis Rare After AVR, but Often a Killer When It Occurs Michael O'Riordan October 01, 2021
News Daily News Women Stand to Gain the Most From Standardized STEMI Protocols Michael O'Riordan September 30, 2021
News Daily News High Burden of CAD in Chest Pain Patients With ‘Normal’ Troponin Michael O'Riordan September 27, 2021
News Daily News Cumulative Burden of LDL Cholesterol Increases CHD Risk Michael O'Riordan September 23, 2021
News Daily News Coronary Revascularization Benefits Even Latecomer STEMI: FAST-MI Registry Michael O'Riordan September 21, 2021
News Conference News AHA Announces Fully Virtual Meeting in Light of Surging COVID-19 Numbers Michael O'Riordan September 17, 2021
News Daily News HFSA 2021 In HF and Diabetes, Mobile Health App Modestly Boosts Physical Activity Michael O'Riordan September 15, 2021
News Conference News HFSA 2021 Digital App Improves HF Quality-of-Care Metrics: CONNECT-AF Michael O'Riordan September 14, 2021
News Daily News Heterozygous FH Diagnosed Late, Remains Undertreated Michael O'Riordan September 13, 2021
News Daily News CMS Pays More to Male Cardiologists, but the Reasons Why Are Murky Michael O'Riordan September 10, 2021
News Daily News Could an App Replace Statin Prescribing by Doctors? Michael O'Riordan September 08, 2021
News Conference News ESC 2021 New ESC Prevention Guidelines Focus on Tailored, Escalating Therapy Michael O'Riordan September 03, 2021
News Conference News ESC 2021 No Attenuation in CVD Risk Reduction for Patients Treated to Very Low LDLs: FOURIER Michael O'Riordan September 02, 2021
News Conference News ESC 2021 Fixed-Dose Combo Therapy Slashes CVD Risk in Primary Prevention Michael O'Riordan August 31, 2021
News Conference News ESC 2021 PRONOUNCE: No Difference in CVD Risks With Degarelix and Leuprolide for Prostate Cancer Michael O'Riordan August 30, 2021